SBBP
Strongbridge Biopharma plc.
SBBP
SBBP
Delisted
SBBP was delisted on the 5th of October, 2021.
77 hedge funds and large institutions have $81.8M invested in Strongbridge Biopharma plc. in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
+8
Holders Change %
+11.59%
% of All Funds
1.56%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
16
Increased
26
Reduced
23
Closed
8
Calls
$37K
Puts
$79K
Net Calls
-$42K
Net Calls Change
-$140K
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$7.33M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$4.04M |
| 3 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$3.1M |
| 4 |
6CM
683 Capital Management
New York
|
+$2.39M |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
+$2.31M |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$491K |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$422K |
| 3 |
D.E. Shaw & Co
New York
|
-$306K |
| 4 |
Walleye Capital
New York
|
-$200K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$143K |
